Bulletin
Investor Alert

NeoGenomics Inc.

NAS: NEO

GO
/marketstate/country/us

After Hours

NEO
/zigman2/quotes/202492506/composite

$

11.68

Change

0.00 0.00%

Volume

Volume 40,026

Aug 9, 2022, 6:24 p.m.

Real time quotes

/zigman2/quotes/202492506/composite

Today's close

$ 10.23

$ 11.68

Change

+1.45 +14.17%

Day low

Day high

$10.35

$12.10

Open
Open: 10.56

52 week low

52 week high

$6.85

$54.74

Open

Market cap

$1.28B

Average volume

2.02M

P/E ratio

N/A

Rev. per Employee

$242,982

EPS

-0.32

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/neo

MarketWatch News on NEO

  1. NeoGenomics downgraded to neutral from buy at BofA Securities

    10:00 a.m. March 29, 2022

    - Tomi Kilgore

  2. NeoGenomics stock price target cut to $18 from $25 at BofA Securities

    10:00 a.m. March 29, 2022

    - Tomi Kilgore

  3. NeoGenomics stock price target cut to $16 from $26 at Benchmark

    8:17 a.m. March 29, 2022

    - Tomi Kilgore

  4. NeoGenomics stock price target cut to $19 from $29 at Needham

    5:59 a.m. March 29, 2022

    - Tomi Kilgore

  5. NeoGenomics downgraded to equal weight at Morgan Stanley

    12:06 p.m. Nov. 8, 2021

    - Tomi Kilgore

  6. NeoGenomics upgraded to outperform from market perform at Raymond James

    7:20 a.m. Oct. 14, 2021

    - Tomi Kilgore

  7. NeoGenomics stock price target cut to $54 from $65 at Truist

    7:31 a.m. May 25, 2021

    - Tomi Kilgore

  8. NeoGenomics stock price target cut to $46 from $60 at Benchmark

    6:25 a.m. May 6, 2021

    - Tomi Kilgore

  9. NeoGenomics downgraded to market perform from outperform at Raymond James

    9:35 a.m. Feb. 25, 2021

    - Tomi Kilgore

  10. NeoGenomics stock price target raised to $64 from $48 at Benchmark

    7:26 a.m. Feb. 5, 2021

    - Tomi Kilgore

  11. NeoGenomics started at buy with $65 stock price target at Truist

    8:43 a.m. Jan. 28, 2021

    - Tomi Kilgore

  12. NeoGenomics stock price target raised to $48 from $40 at Benchmark

    6:13 a.m. Oct. 28, 2020

    - Tomi Kilgore

  13. Like Amazon, these stocks have 100% buy ratings from analysts

    7:24 a.m. April 25, 2019

    - Philip van Doorn

  14. NeoGenomics stock price target raised to $23 from $20 at SVB Leerink

    8:30 a.m. Feb. 20, 2019

    - Tomi Kilgore

  15. GE Has Slashed Its Stake in Tellurian Stock

    7:12 p.m. Feb. 19, 2019

    - Barron's Online

  16. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/neo

Other News on NEO

  1. NeoGenomics rises ~14% on strong Q2 result

    11:52 a.m. Today

    - Seeking Alpha

  2. NeoGenomics (NEO) Reports Q2 Loss, Tops Revenue Estimates

    8:25 a.m. Today

    - Zacks.com

  3. NeoGenomics Q2 2022 Earnings Preview

    2:14 p.m. Aug. 8, 2022

    - Seeking Alpha

  4. Notable earnings before Tuesday's open

    10:46 a.m. Aug. 8, 2022

    - Seeking Alpha

  5. Techne (TECH) Lags Q4 Earnings Estimates

    7:55 a.m. Aug. 4, 2022

    - Zacks.com

  6. NeoGenomics gets new CEO

    7:30 a.m. July 21, 2022

    - Seeking Alpha

  7. Thoughts On An Ageing Bear Market

    2:46 a.m. July 11, 2022

    - Seeking Alpha

  8. Carillon Scout Small Cap Fund Q1 2022 Commentary

    11:13 a.m. June 1, 2022

    - Seeking Alpha

  9. Loading more headlines...

Earnings Announcement

/news/pressrelease/company/us/neo

Press Releases on NEO

  1. NeoGenomics Reports Revenue of $125 Million in the Second Quarter

    7:01 a.m. Today

    - ACCESSWIRE

  2. Liquid Biopsy Market Share to Witness Steady Rise by 2029

    12:52 a.m. Aug. 4, 2022

    - AmericaNewsHour

  3. NeoGenomics Announces Chief Executive Officer Appointment

    7:00 a.m. July 21, 2022

    - ACCESSWIRE

  4. Vanguard Announces Cash Distributions for the Vanguard ETFs

    2:37 p.m. June 24, 2022

    - GlobeNewswire

  5. Lost Money in NeoGenomics, Inc.?

    9:20 p.m. June 3, 2022

    - BusinessWire - BZX

  6. Loading more headlines...

Rates »

Link to MarketWatch's Slice.